ConductScience.org, home

Paper765184

Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.

Behar J and 1 other. Gastroenterology, 1976. Cited by 59 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. Papers, record 765184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/765184

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.
PubMed
Journal
Gastroenterology
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Behar JJ
2Biancani PP

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EatingMajor topic
Gastroesophageal RefluxMajor topic
MetoclopramideMajor topic
Administration, Oral
Adult
Clinical Trials as Topic
Dietary Proteins
Esophagitis, Peptic
Esophagogastric Junction
Humans
Male
Middle Aged
Placebos
Pressure
Time Factors

Source PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
8,082,490Metoclopramide inhibits development of esophageal varices in rat model.Dig Dis Sci1994https://conductscience.org/library/papers/8082490PubMed
6,345,129Metoclopramide. An updated review of its pharmacological properties and clinical use.Drugs1983https://conductscience.org/library/papers/6345129PubMed
3,338,36524-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.Dig Dis Sci1988https://conductscience.org/library/papers/3338365PubMed
1,551,349Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.Dig Dis Sci1992https://conductscience.org/library/papers/1551349PubMed
786,607Metoclopramide: a review of its pharmacological properties and clinical use.Drugs1976https://conductscience.org/library/papers/786607PubMed
732,429[Indication for conservative therapy of reflux esophagitis (author's transl)].Langenbecks Arch Chir1978https://conductscience.org/library/papers/732429PubMed
378,623L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.Dig Dis Sci1979https://conductscience.org/library/papers/378623PubMed
23,983Postprandial gastro-oesophageal reflux in healthy people.Gut1977https://conductscience.org/library/papers/23983PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/765184

GET https://conductscience.org/api/papers/v1/765184/authors